Co-administration of Cabergoline and Gliclazide Improve Glycemic Parameters and Lipid Profile in T2DM Patients

NCT03313661 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Diabetes

Interventions

DRUG: Cabergoline
DRUG: Gliclazide

Sponsor

Sherief Abd-Elsalam